1-6 of 6
John Lust, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Martha Lacy, MD, Sumithra Mandrekar, PhD, Morie Abraham A Gertz, MD, Suzanne R. Hayman, MD, Kristen Detweiler Short, RN, CNP, Francis Buadi, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Steven Zeldenrust, MD, PhD, David Dingli, M.D., Ph.D., Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Vivek Roy, MD, A. Keith Stewart, MD, Jacob Allred, Kristina Laumann, Craig B. Reeder, MD, S. Vincent Rajkumar, MD, Joseph R. Mikhael, MD
Journal: Blood
Blood (2010) 116 (21): 863.
https://doi.org/10.1182/blood.V116.21.863.863
Published: 2010
Journal Articles

Multi-Parameter Flow Cytometry(FC) Can Detect Proliferating Myeloma Cells After Treatment: Implications for Targeting the Myeloma Proliferative Component

John Lust, MD, PhD, Shaji Kumar, MD, Michael Timm, Kathleen Donovan, PhD, Philip R. Greipp, MD, William Morice, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4995.
https://doi.org/10.1182/blood.V116.21.4995.4995
Published: 2010
Journal Articles

Reduction In Proliferative Rate of Myeloma Plasma Cells Measured by the Plasma Cell Labeling Index Predicts Improved Survival In Multiple Myeloma

Jeremy T Larsen, MD, Cheng E. Chee, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2010) 116 (21): 4048.
https://doi.org/10.1182/blood.V116.21.4048.4048
Published: 2010
Journal Articles

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Sumit Madan, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Gertz, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, Kristen Detweiler-Short, David Dingli, M.D., Ph.D., Steven Zeldenrust, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 1964.
https://doi.org/10.1182/blood.V116.21.1964.1964
Published: 2010
Journal Articles

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Shaji Kumar, MD, Morie Gertz, MD, Martha Lacy, MD, David Dingli, MD, PhD, Suzanne R. Hayman, MD, Francis Buadi, MD, Kristen Detweiler-Short, Steven Zeldenrust, MD, Nelson Leung, MD, Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Vincent Rajkumar, Angela Dispenzieri, MD
Journal: Blood
Blood (2010) 116 (21): 1892.
https://doi.org/10.1182/blood.V116.21.1892.1892
Published: 2010
Journal Articles

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Suzanne Hayman, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Rafael Fonseca, MD, Susan Geyer, PhD, Shaji Kumar, MD, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, John Lust, MD, PhD, Robert Kyle, MD, Philip Greipp, MD, Thomas Witzig, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2006) 108 (11): 3568.
https://doi.org/10.1182/blood.V108.11.3568.3568
Published: 2006